Theralase Technologies Inc. V.TLT

75 to 100 patients

[enriquesuave]

Like someone mentioned it's the first time they use 75-100 instead of 100-125 patients.  Perhaps the FDA gave them the green light to stop at 75 if data in BTD submission is good?  It is we know, but could that be a possibility?

[toade1313]

The. Number 75 is what we will have when those recently registered become patients. The FDA has not chaged the 100 number.

[Eoganacht]

Here is what Mr. Dumoulin-White said in today's video: "We've been able to enrol and treat 72 patients to date - with another 3 coming up in the next 4 to 6 weeks - gives us around 75 patients. Why that's exciting is one of our competitors just achieved FDA approval in May with 77 patients. So we're very, very close. We expect to enrol anther 10 patients by the end of

[DJDawg]

I hope that the scenario that is unfolding is as follows. TLT can point out the status of the competitions N803/Anktiva plus BCG: 2 agents. Many instillations over long period to achieve 40% of patients maintaining the achieved CR past 24 montsh. Also requires BCG in short supply still. Adstiladrin: many instillations. Only 3.9% keeping the CR past 24 months. Go back to FDA pre-BTD reviewer and

[Kayz88]

Do you have the link to the video? 

[O12009]

Please click the Press Release link to view our latest news release, which includes our second quarter financials and our much-anticipated update on our late-stage clinical trial. Key highlights from the Press Release: 72 Patients treated 63% Complete Response 48% Duration of Complete Response at 1 year 44% Duration of Complete Response at 15 months 90% of

[Yajne]

Kayz,,,can't seem to copy a link that works properly but the video is "Watchlist" on Stockhouse, in right column next to this bullboard.